Proposed Data Collection Submitted for Public Comment and Recommendations, 28356-28357 [2021-11148]
Download as PDF
<![CDATA[
28356
Federal Register / Vol. 86, No. 100 / Wednesday, May 26, 2021 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–1102; Docket No. CDC–2021–
0050]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Tuberculosis Data from Panel
Physicians. This study collects
Tuberculosis data gathered during
overseas immigration medical exams.
DATES: Written comments must be
received on or before July 26, 2021.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2021–
0050 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7118; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
SUMMARY:
VerDate Sep<11>2014
20:00 May 25, 2021
Jkt 253001
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Information Collection for
Tuberculosis Data from Panel
Physicians (OMB Control No. 0920–
1102, Exp. 9/30/2021)—Revision—
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention’s (CDC), National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Division of Global
Migration and Quarantine (DGMQ),
Immigrant, Refugee, and Migrant Health
Branch (IRMH), requests approval for a
Revision of an existing information
collection. This project pertains to
collecting annual reports on certain
tuberculosis data from U.S. panel
physicians.
The respondents are panel physicians.
More than 760 panel physicians from
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
336 panel sites perform overseas predeparture medical examinations in
accordance with requirements, referred
to as technical instructions, provided by
DGMQs Quality Assessment Program
(QAP). The role of QAP is to assist and
guide panel physicians in the
implementation of the technical
instructions; evaluate the quality of the
overseas medical examination for U.S.bound immigrants and refugees; assess
potential panel physician sites; and
provide recommendations to the U.S.
Department of State in matters of
immigrant medical screening.
To achieve DGMQ’s mission, IRMH
works with domestic and international
programs to improve the health of U.S.bound immigrants and refugees to
protect the U.S. public by preventing
the importation of infectious disease.
These goals are accomplished through
IRMH’s oversight of medical exams
required for all U.S.-bound immigrants
and refugees who seek permanent
residence in the U.S. IRMH is
responsible for assisting and training the
international panel physicians with the
implementation of medical exam
Technical Instructions (TI). Technical
Instructions are detailed requirements
and national policies regarding the
medical screening and treatment of all
U.S.-bound immigrants and refugees.
Screening for tuberculosis (TB) is a
particularly important component of the
immigration medical exam and allows
panel physicians to diagnose active TB
disease prior to arrival in the United
States. As part of the TI requirements,
panel physicians perform chest x-rays
and laboratory tests that aid in the
identification of TB infection (Class B1
applicants) and diagnosis of active TB
disease (Class A, inadmissible
applicants). CDC uses these
classifications to report new immigrant
and refugee arrivals with a higher risk
of developing TB disease to U.S. state
and local health departments for further
follow-up. Some information that panel
physicians collect as part of the medical
exam is not reported on the standard
Department of State forms (DS-forms),
thereby preventing CDC from evaluating
TB trends in globally mobile
populations and monitoring program
effectiveness.
Currently, CDC is requesting this data
be sent by panel physicians once per
year. The consequences of reducing this
frequency would be the loss of
monitoring program impact and TB
burdens in mobile populations, and
immigrants and refugees coming to the
United States on an annual basis. The
total burden hours requested is 999.
There is no cost to the respondents
other than their time.
E:\FR\FM\26MYN1.SGM
26MYN1
28357
Federal Register / Vol. 86, No. 100 / Wednesday, May 26, 2021 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)
Number of
responses per
respondent
Number of
respondents
Total burden
(in hours)
Type of respondents
Form name
International Panel Physicians ..........
TB Indicators REDCap web form ....
333
1
3
999
Total ...........................................
...........................................................
........................
........................
........................
999
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–11148 Filed 5–25–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day-21–0222; Docket No. CDC–2021–
0051]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled the Collaborating Center for
Questionnaire Design and Evaluation
Research (CCQDER). This generic
clearance request, requests approval for
collection of information that
encompasses general questionnaire
development, pre-testing, and
measurement-error reduction activities
to be carried out in 2021–2024.
DATES: CDC must receive written
comments on or before July 26, 2021.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2021–
0051 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
SUMMARY:
VerDate Sep<11>2014
20:22 May 25, 2021
Jkt 253001
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7118; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
The Collaborating Center for
Questionnaire Design and Evaluation
Research (CCQDER) (OMB Control No.
0920–0222, Exp. 08/31/2021)—
Revision—National Center for Health
Statistics (NCHS), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Section 306 of the Public Health
Service (PHS) Act (42 U.S.C. 242k), as
amended, authorizes that the Secretary
of Health and Human Services (DHHS),
acting through NCHS, shall undertake
and support (by grant or contract)
research, demonstrations, and
evaluations respecting new or improved
methods for obtaining current data to
support statistical and epidemiological
activities for the purpose of improving
the effectiveness, efficiency, and quality
of health services in the United States.
The Collaborating Center for
Questionnaire Design and Evaluation
Research (CCQDER) is the focal point
within NCHS for questionnaire and
survey development, pre-testing, and
evaluation activities for CDC surveys
such as; the National Survey of Family
Growth (NSFG) (OMB Control No.
0920–0314), the Research and
Development Survey (RANDS),
including RANDS COVID (OMB Control
No. 0920–1298), and other federallysponsored surveys. The CCQDER is
requesting three additional years of
OMB Clearance for this generic
submission.
The CCQDER and other NCHS
programs conduct cognitive interviews,
focus groups, in-depth or ethnographic
interviews, usability tests, field tests/
pilot interviews, and experimental
research in laboratory and field settings,
both for applied questionnaire
development and evaluation, as well as
E:\FR\FM\26MYN1.SGM
26MYN1
]]>Agencies
[Federal Register Volume 86, Number 100 (Wednesday, May 26, 2021)]
[Notices]
[Pages 28356-28357]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-11148]
[[Page 28356]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-21-1102; Docket No. CDC-2021-0050]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Tuberculosis Data from Panel
Physicians. This study collects Tuberculosis data gathered during
overseas immigration medical exams.
DATES: Written comments must be received on or before July 26, 2021.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0050 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7118; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Information Collection for Tuberculosis Data from Panel Physicians
(OMB Control No. 0920-1102, Exp. 9/30/2021)--Revision--National Center
for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention's (CDC), National
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division
of Global Migration and Quarantine (DGMQ), Immigrant, Refugee, and
Migrant Health Branch (IRMH), requests approval for a Revision of an
existing information collection. This project pertains to collecting
annual reports on certain tuberculosis data from U.S. panel physicians.
The respondents are panel physicians. More than 760 panel
physicians from 336 panel sites perform overseas pre-departure medical
examinations in accordance with requirements, referred to as technical
instructions, provided by DGMQs Quality Assessment Program (QAP). The
role of QAP is to assist and guide panel physicians in the
implementation of the technical instructions; evaluate the quality of
the overseas medical examination for U.S.-bound immigrants and
refugees; assess potential panel physician sites; and provide
recommendations to the U.S. Department of State in matters of immigrant
medical screening.
To achieve DGMQ's mission, IRMH works with domestic and
international programs to improve the health of U.S.-bound immigrants
and refugees to protect the U.S. public by preventing the importation
of infectious disease. These goals are accomplished through IRMH's
oversight of medical exams required for all U.S.-bound immigrants and
refugees who seek permanent residence in the U.S. IRMH is responsible
for assisting and training the international panel physicians with the
implementation of medical exam Technical Instructions (TI). Technical
Instructions are detailed requirements and national policies regarding
the medical screening and treatment of all U.S.-bound immigrants and
refugees.
Screening for tuberculosis (TB) is a particularly important
component of the immigration medical exam and allows panel physicians
to diagnose active TB disease prior to arrival in the United States. As
part of the TI requirements, panel physicians perform chest x-rays and
laboratory tests that aid in the identification of TB infection (Class
B1 applicants) and diagnosis of active TB disease (Class A,
inadmissible applicants). CDC uses these classifications to report new
immigrant and refugee arrivals with a higher risk of developing TB
disease to U.S. state and local health departments for further follow-
up. Some information that panel physicians collect as part of the
medical exam is not reported on the standard Department of State forms
(DS-forms), thereby preventing CDC from evaluating TB trends in
globally mobile populations and monitoring program effectiveness.
Currently, CDC is requesting this data be sent by panel physicians
once per year. The consequences of reducing this frequency would be the
loss of monitoring program impact and TB burdens in mobile populations,
and immigrants and refugees coming to the United States on an annual
basis. The total burden hours requested is 999. There is no cost to the
respondents other than their time.
[[Page 28357]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
International Panel Physicians TB Indicators 333 1 3 999
REDCap web form.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 999
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-11148 Filed 5-25-21; 8:45 am]
BILLING CODE 4163-18-P
